SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Premium Written

NameSupplementaryInsuranceInformationPremiumsWritten
Namespacehttp://fasb.org/us-gaap/2020-01-31
Prefixus-gaap
Data typexbrli:monetaryItemType
Period typeduration
Substitution Groupxbrli:item
Balancecredit
NillableTrue
AbstractFalse

Labels

TextLangRoleContainer role
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Premium Writtenen-UShttp://www.xbrl.org/2003/role/labelhttp://www.xbrl.org/2003/role/link
Amount, after premiums ceded and assumed, of premium written, disclosed in supplementary insurance information.en-UShttp://www.xbrl.org/2003/role/documentationhttp://www.xbrl.org/2003/role/link

References

NameValueRole
NoteElement is intended to be used for financial statement schedule specified by Securities and Exchange Commission Regulation S-X.http://fasb.org/us-gaap/role/tin/taxonomyImplementationNote
PublishDate2018-01http://fasb.org/us-gaap/role/tin/taxonomyImplementationNote
TaxonomyVersion2018http://fasb.org/srt/role/changeNote/changeNote
ChangeDate2017-08http://fasb.org/srt/role/changeNote/changeNote
ModifiedReferencestruehttp://fasb.org/srt/role/changeNote/changeNote
ModifiedLabelstruehttp://fasb.org/srt/role/changeNote/changeNote
ModifiedDocumentationtruehttp://fasb.org/srt/role/changeNote/changeNote
PreviousDocumentationAmount of actual written premiums, including, as applicable, premiums from reinsurance assumed and net of premiums on reinsurance ceded.http://fasb.org/srt/role/changeNote/changeNote
PublisherFASBhttp://www.xbrl.org/2003/role/disclosureRef
NameAccounting Standards Codificationhttp://www.xbrl.org/2003/role/disclosureRef
Topic944http://www.xbrl.org/2003/role/disclosureRef
SubTopic235http://www.xbrl.org/2003/role/disclosureRef
SectionS99http://www.xbrl.org/2003/role/disclosureRef
Paragraph1http://www.xbrl.org/2003/role/disclosureRef
Subparagraph(SX 210.12-16(Column K))http://www.xbrl.org/2003/role/disclosureRef
URIhttp://asc.fasb.org/extlink&oid=120401096&loc=d3e574960-122915http://www.xbrl.org/2003/role/disclosureRef